Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom

Author： Aggarwal N. Zhang Z. Cox S. Statham R. Alexandersen S. Kitching R.P. Barnett P.V.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.19, 2002-06, pp. : 2508-2515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C 1 -Barcelona

By Gomes P. Giralt E. Andreu D.

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3459-3466

Elsevier

Access to resources Recommend Favorite

Synthetic vaccine against foot-and-mouth disease based on a palmitoyl derivative of the VP 1 protein 135-159 fragment of the A 22 virus strain

By Volpina O.M. Yarov A.V. Zhmak M.N. Kuprianova M.A. Chepurkin A.V. Toloknov A.S. Ivanov V.T.

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1375-1380

Elsevier

Access to resources Recommend Favorite

Gene gun-mediate DNA vaccination against foot-and-mouth disease virus

By Benvenisti L. Rogel A. Kuznetzova L. Bujanover S. Becker Y. Stram Y.

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3885-3895

Elsevier

Access to resources Recommend Favorite

Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines

By Twomey T. Newman J. Burrage T. Piatti P. Lubroth J. Brown F.

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1603-1610

Elsevier

Access to resources Recommend Favorite

Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine

By Moraes M.P. Chinsangaram J. Brum M.C.S. Grubman M.J.

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 268-279

Elsevier

Access to resources Recommend Favorite